Aura Biosciences AURA
NASDAQ AURA
$7.61 -0.04 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Aura Biosciences (AURA) Other financing activities (as filed) (2020 - 2021)

Updated

Aura Biosciences (AURA) recorded Other financing activities of -$15,000 in FY2021, compared with -$34,000 in FY2020.

Analysis

Aura Biosciences (AURA) Other financing activities (as filed) (2020 - 2021) Analysis & Trends

  • Per Business Quant data, AURA's Other financing activities was -$34,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Aura Biosciences 796.17 Mn 542.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 1.40 Mn
Sep 30, 2021 -1.14 Mn
Jun 30, 2021 -271,000.00
Mar 31, 2021 -9,000.00
Dec 31, 2020 -9,000.00
API Access

Aura Biosciences Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AURA&period=max&api_key=YOUR_API_KEY